"Valuation of Pharmaceutical Manufacturing Facility - THC...

"Valuation of Pharmaceutical Manufacturing Facility - THC announced the purchase of the largest southern hemisphere pharmaceutical botanicals extractionand purification facility (the Southport Manufacturing Facility), as well as land and building in Southportin April 2018. The acquisition added significant and immediate capability to THC in its plan to providedomestic medicinal cannabis manufacture capability for near term domestic and export supply.The Board has sought an independent external valuation from global valuation firm AON ValuationServices of THC’s Southport Manufacturing Facility assets in Queensland, Australia which has valued theSouthport Manufacturing Facility assets at $14.58 million at market value. With land and building atacquisition price, the combined value of THC’s Southport Manufacturing Facility, will be recognised in theCompany’s June 2018 Half Year Accounts at $16.68 million.Having been advised of the costs of constructing the Southport Manufacturing Facility by its previousowner, THC has assessed the replacement value to be in the range of $35 million, and has insured theproperty on that basis. The Board may revisit the valuation as the Company ramps up into revenuegenerating full scale pharma-grade production in the near term. "

Stamp Duty has nothing to do with it. The price paid has nothing to do with the current value of the asset.

1.2 mil Revenue with a 600k profit in the last 6 months is only worth a couple hundred thousand in good will.... Your method of valuing CMDV seems lower then what most people would think.

The rest is in the "self-indulgent" EGM notice. The answer generally was the shares are in lieu of remuneration. You failing to read the explanatory notice is not a lack of transparency.